By activating AMPK to inhibit mTOR, metformin prevents cell loss during hypoxia [178], reduces cardiomyopathy in experimental models of DM [179], increases cardiomyocyte cell survival [46], and protects cortical brain tissue during cerebral ischemia [110]. This evidence concerns the gene MTOR and diabetes mellitus.